Some previous studies showed that patients with small tumors receiving systemic therapy were significantly younger and had lymph node metastasis, higher tumor grade, negative ER, and positive HER2 status (28–30). The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.